Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.
By L. Silverman, R. Gelber, V. Dalton, B. Asselin, R. Barr, L. Clavell, C. Hurwitz, A. Moghrabi, Y. Samson, M. Schorin and 4 more. Blood, 2001
882 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/066751721eb577817f14fbc4e67c4eb1916086ab
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pediatrics, Perinatology and Child Health
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. (2003, neutral): “9 [15,2-20] .”
- Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. (2002, background): “…heterogeneous collection of leukemias that were not assigned to one of these band q23, or a hyperdiploid karyotype (i.e., Ͼ50 chromosomes), and T lineage leukemias (T-ALL; Silverman et al., 2001; Pui and subtypes, a subgroup of 14 cases was identified that had a distinct gene expression profile.”